sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Biotechnology Asia Pacific Cancer Tissue Diagnostics Market...

Asia Pacific Cancer Tissue Diagnostics Market to 2027 - Regional Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Country

TIPRE00008093 | Pages: 150 | Biotechnology | Jan 2020 | Type: Regional | Status: Published

The Asia Pacific Cancer tissue diagnostics market is expected to reach US$ 730.09 Mn in 2027 from US$ 410.78 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.

The growth of the market is driven by factors such as the rising number of cancer patients in the Asia Pacific and technological advancements and product launches in Asian countries whereas the lack of resources and awareness for cancer screening and treatment in poor/ less developed countries is likely to have a negative impact on the growth of the Cancer Tissue Diagnostics market in the coming years.

 

Developing countries in Asia have limited or fewer healthcare resources and hence use different strategies to diagnose different types of cancer. In developing poor countries, most of the population relies on the public healthcare systems as the healthcare infrastructures are poor in these countries. Despite advancements in the pharmaceuticals and treatment procedures, cancer is diagnosed in the advanced stages in developing countries as early detection or diagnosis, and treatment is not efficiently promoted.

Many of the low- and middle-income countries (LMICs) in Asia have very poor healthcare services, and the cancer burden is substantial in these countries. Despite the increasing burden of cancer, the disease is still a low priority in healthcare planning and expenditure in most of the Asian LMICs.

Furthermore, South Asian women show lower uptake of breast screening services, especially those from lower socioeconomic groups. Screening rates are low in South Asian populations because they have poor knowledge and awareness of cancer, low community awareness, poor communication between patients and healthcare professionals, and limited access to cancer health services. Thus cancer mortality is high in LMICs as compared with high-income countries (HICs).

 

There has been rise in cancer incidence and mortality rates in China, making cancer the leading cause of death since 2010 in the country. Much of the rising burden is due to population growth, aging population, and socio-demographic changes. As per data revealed by the WHO, an approximate 4.3 million new cases of cancer were detected as well as 2.9 million cancer deaths were recorded in the country during the year 2018. The prevalence of cancer, coupled with various technological advancements for detection is anticipated to fuel the growth of the market in China during the forecast period.

 

Rest of Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Rest of Asia Pacific Cancer Tissue Diagnostics market Revenue and Forecasts to 2027 (US$ Mn)

Get more information on this report :


 

ASIA PACIFIC CANCER TISSUE DIAGNOSTICS – MARKET SEGMENTATION

By Test Type

  • Immunohistochemical Tests
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Stomach Cancer
    • Others
  • In Situ Hybridization Tests
    • Breast Cancer
    • Lung Cancer
    • Bladder Cancer
    • Others

By Country

  • China
  • Japan
  • India
  • Australia
  • South Korea

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Bio Rad Laboratories Inc.
  • Abbott
  • Enzo Life Sciences, Inc.
  • Agilent Technologies, Inc.
  • Cancer Genetics Inc.
  • Merck KGaA (Sigma-Aldrich Co. LLC)
  • Danaher Corporation
  • Abcam plc.

 

1.           Introduction

1.1         Scope Of The Study

1.2         The Insight Partners Research Report Guidance

2.           Asia Pacific Cancer Tissue Diagnostics Market – Key Takeaways

3.           Asia Pacific Cancer Tissue Diagnostics Market – Market Landscape

3.1         Overview

3.2         Market Segmentation

3.2.1        Asia Pacific Cancer Tissue Diagnostics Market – By Test Type

3.2.2        Asia Pacific Cancer Tissue Diagnostics Market – By Country

3.3         PEST Analysis

3.4         Expert Opinions

4.           Asia Pacific Cancer Tissue Diagnostics Market-Key Market Dynamics

4.1         Key Market Drivers

4.1.1        Rising Number of Cancer Patients In Asia Pacific

4.1.2        Technological Advancements and Product Launches in Asian Countries

4.2         Key Market Restraints

4.2.1        Lack Of Resources and Awareness For Cancer Screening And Treatment in Poor/ Less Developed Countries

4.3         Key Market Opportunities

4.3.1        Emerging Countries in Asia Pacific Region

4.4         Future Trends

4.4.1        Growing Trend of Personalized Medicine

4.5         Impact Analysis Of Drivers And Restraints

5.           Cancer Tissue Diagnostics Market – Asia Pacific Analysis

5.1         Asia Pacific Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis

5.2         Performance of Key Players

6.           Asia Pacific Cancer Tissue Diagnostics Market Analysis– by Test Type

6.1         Overview

6.2         Asia Pacific Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)

6.3         Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027, By Type Of Fitting (Us$ Mn)

6.4         Immunohistochemical Tests Market

6.4.1        Overview

6.4.2        Asia Pacific Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)

6.4.3        Breast Cancer Market

6.4.3.1          Overview

6.4.3.2          Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

6.4.4        Colorectal Cancer Market

6.4.4.1          Overview

6.4.4.2          Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

6.4.5        Prostate Cancer Market

6.4.5.1          Overview

6.4.5.2          Asia Pacific Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

6.4.6        Stomach Cancer Market

6.4.6.1          Overview

6.4.6.2          Asia Pacific Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

6.4.7        Others Market

6.4.7.1          Overview

6.4.7.2          Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

6.5         In Situ Hybridization Tests Market

6.5.1        Overview

6.5.2        Asia Pacific In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)

6.5.3        Breast Cancer Market

6.5.3.1          Overview

6.5.3.2          Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

6.5.4        Lung Cancer Market

6.5.4.1          Overview

6.5.4.2          Asia Pacific Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

6.5.5        Bladder Cancer Market

6.5.5.1          Overview

6.5.5.2          Asia Pacific Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

6.5.6        Others Market

6.5.6.1          Overview

6.5.6.2          Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.           Asia Pacific Cancer Tissue Diagnostics Market

7.1         Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027

7.1.1        Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.2        Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

7.1.2.1          Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.2.2          Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.3        Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

7.1.4        Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.4.1          Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.4.2          Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

7.1.4.2.1          Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.4.2.2          Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.5        China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.5.1          China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.5.2          China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

7.1.5.2.1          China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.5.2.2          China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.6        India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.6.1          India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.6.2          India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

7.1.6.2.1          India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.6.2.2          India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.7        South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.7.1          South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.7.2          South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

7.1.7.2.1          South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.7.2.2          South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.8        Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.8.1          Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.1.8.2          Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

7.1.8.2.1          Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

7.1.8.2.2          Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.           Cancer Tissue Diagnostics Market– Industry Landscape

8.1         Overview

8.2         Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019

8.3         Organic Growth Strategies

8.3.1        Overview

8.4         Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

8.4.1        Product Launches

8.4.1.1          Recent Product Launches By Players In The Cancer Tissue Diagnostics Market

8.4.2        Product Approvals

8.4.2.1          Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market

8.4.3        Expansion & Other Activities

8.4.3.1          Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market

8.4.4        Product Enhancements

8.4.4.1          Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market

8.5         Inorganic Growth Strategies

8.5.1        Overview

8.6         Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

8.6.1        Agreements

8.6.1.1          Recent Agreements By Players In The Cancer Tissue Diagnostics Market

8.6.2        Partnerships & Collaborations

8.6.2.1          Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market

8.6.3        Acquisitions

8.6.3.1          Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market

9.           Cancer Tissue Diagnostics Market–Key Company Profiles

9.1         Bio-Rad Laboratories, Inc.

9.1.1        Key Facts

9.1.2        Business Description

9.1.3        Financial Information

9.1.4        Product Portfolio

9.1.5        SWOT Analysis

9.1.6        Key Developments

9.2         Thermo Fisher Scientific, Inc.

9.2.1        Key Facts

9.2.2        Business Description

9.2.3        Financial Information

9.2.4        Product Portfolio

9.2.5        SWOT Analysis

9.2.6        Key Developments

9.3         F. Hoffmann-La Roche Ltd.

9.3.1        Key Facts

9.3.2        Business Description

9.3.3        Financial Overview

9.3.4        Product Portfolio

9.3.5        SWOT Analysis

9.3.6        Key Developments

9.4         Abbott

9.4.1        Key Facts

9.4.2        Business Description

9.4.3        Financial Overview

9.4.4        Product Portfolio

9.4.5        SWOT Analysis

9.4.6        Key Developments

9.5         Enzo Biochem Inc.

9.5.1        Key Facts

9.5.2        Business Description

9.5.3        Financial Overview

9.5.4        Product Portfolio

9.5.5        SWOT Analysis

9.5.6        Key Developments

9.6         Agilent Technologies, Inc.

9.6.1        Key Facts

9.6.2        Business Description

9.6.3        Financial Overview

9.6.4        Product Portfolio

9.6.5        SWOT Analysis

9.6.6        Key Developments

9.7         Cancer Genetics Inc.

9.7.1        Key Facts

9.7.2        Business Description

9.7.3        Financial Overview

9.7.4        Product Portfolio

9.7.5        SWOT Analysis

9.7.6        Key Developments

9.8         Merck Kgaa (Sigma-Aldrich)

9.8.1        Key Facts

9.8.2        Business Description

9.8.3        Financial Overview

9.8.4        Product Portfolio

9.8.5        SWOT Analysis

9.8.6        Key Developments

9.9         Abcam Plc.

9.9.1        Key Facts

9.9.2        Business Description

9.9.3        Financial Overview

9.9.4        Product Portfolio

9.9.5        SWOT Analysis

9.9.6        Key Developments

9.10      Danaher

9.10.1     Key Facts

9.10.2     Business Description

9.10.3     Financial Information

9.10.4     Product Portfolio

9.10.5     SWOT Analysis

9.10.6     Key Developments

10.        Appendix

10.1      About The Insight Partners

10.2      Glossary Of Terms

10.3      Methodology

10.3.1     Coverage

10.3.2     Secondary Research

10.3.3     Primary Research

LIST OF TABLES

Table 1.            Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2025, By Test Type (US$ Mn)

Table 2.            Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 3.            Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 4.            Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 5.            Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 6.            Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 7.            Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 8.            China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 9.            China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 10.         China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 11.         India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 12.         India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 13.         India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 14.         South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 15.         South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 16.         South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 17.         Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)

Table 18.         Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 19.         Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 20.         Recent Product Launches in the Cancer Tissue Diagnostics Market

Table 21.         Recent product Approvals in the Cancer Tissue Diagnostics Market

Table 22.         Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market

Table 23.         Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market

Table 24.         Recent Agreements By Players In The Cancer Tissue Diagnostics Market

Table 25.         Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market

Table 26.         Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market

Table 27.         Glossary of Terms, Cancer Tissue Diagnostics Market

LIST OF FIGURES

Figure 1.          China Cancer Tissue Diagnostics Market, Revenue (US$ Mn), By 2018 & 2027

Figure 2.          Global Cancer Tissue Diagnostics Market By Test Type, Market Share (%), 2018

Figure 3.          Cancer Tissue Diagnostics Market Segmentation

Figure 4.          Asia - Pacific: PEST Analysis

Figure 5.          Cancer Tissue Diagnostics Market Impact Analysis Of Driver And Restraint

Figure 6.          Asia Pacific Cancer Tissue Diagnostics Market – Revenue Forecasts And Analysis – 2017- 2027

Figure 7.          Prominent Players in the Cancer Tissue Diagnostics Market

Figure 8.          Asia Pacific Cancer Tissue Diagnostics Market, by Test Type 2018 & 2027 (%)

Figure 9.          Asia Pacific Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 10.       Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.       Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.       Asia Pacific Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.       Asia Pacific Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.       Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.       Asia Pacific In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.       Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.       Asia Pacific Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.       Asia Pacific Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.       Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.       Asia Pacific Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)

Figure 21.       Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.       Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)

Figure 23.       Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.       China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.       India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.       South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.       Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.       Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019

Figure 29.       Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)

Figure 30.       Inorganic Developments in the Cancer Tissue Diagnostics Market, 2016-2019(%)

The List of Companies - Asia Pacific Cancer Tissue Diagnostics Market

  1. F. Hoffmann-La Roche Ltd
  2. Thermo Fisher Scientific Inc.
  3. Bio Rad Laboratories Inc.
  4. Abbott
  5. Enzo Life Sciences, Inc.
  6. Agilent Technologies, Inc.
  7. Cancer Genetics Inc.
  8. Merck KGaA (Sigma-Aldrich Co. LLC)
  9. Danaher Corporation
  10. Abcam plc.

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer tissue diagnostics market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific cancer tissue diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an.. May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec.. May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription